FORE Biotherapeutics Announces Oral Presentation of Phase 1/2a Plixorafenib Data at the Society for Neuro-Oncology 2023 Annual Meeting
PHILADELPHIA–(BUSINESS WIRE)–FORE Biotherapeutics today announced an oral presentation highlighting updated Phase 1/2a clinical data for plixorafenib... Read more.
Soho House & Co Inc. Announces Third Quarter 2023 Results
LONDON–(BUSINESS WIRE)–$SHCO–Soho House & Co Inc. (NYSE: SHCO) (“SHCO,” “Company,” “we” or “our”), a global membership platform... Read more.
JCR Pharmaceuticals Announces First Patient Dosed in a Global Phase I/II Clinical Trial of JR-441 for the Treatment of MPS IIIA
HYOGO, Japan–(BUSINESS WIRE)–JCR Pharmaceuticals Co., Ltd. (TSE 4552; Chairman and President: Shin Ashida; “JCR”) announced today that the first... Read more.
Global Foot Care Products Strategic Analysis Report 2023: Market to Reach $4.4 Billion by 2030 from $2.9 Billion in 2022 – Manufacturers Focus on Enabling Self-Care, Educating Customers – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Foot Care Products – Global Strategic Business Report” has been added to ResearchAndMarkets.com’s... Read more.
FDA Grants Orphan Drug Designation to MAIA Biotechnology for THIO as a Treatment for Glioblastoma
Third orphan drug designation (ODD) granted to THIO by the FDA; drug also holds ODDs for hepatocellular carcinoma and small cell lung cancer Benefits include 7 years... Read more.
Precision BioSciences to Present at Upcoming Sidoti Conference
DURHAM, N.C.–(BUSINESS WIRE)–Precision BioSciences, Inc. (Nasdaq: DTIL), an advanced gene editing company utilizing its novel proprietary ARCUS® platform... Read more.
Electra Provides Notice of Third Quarter 2023 Results Conference Call and Webcast
TORONTO–(BUSINESS WIRE)–$ELBM—Electra Battery Materials Corporation (NASDAQ: ELBM; TSX-V: ELBM) (“Electra”) will release its third quarter... Read more.
Imvax to Present New Data on Lead Program, IGV-001, at 2023 SNO Annual Meeting
PHILADELPHIA–(BUSINESS WIRE)–Imvax, Inc., a clinical-stage biotechnology company developing personalized, whole tumor-derived immunotherapies, today... Read more.
NCIP Client Miguel Solorio Freed After 25 Years of Wrongful Incarceration
LA District Attorney Concedes Conviction Reversal and Dismisses Case SANTA CLARA, Calif.–(BUSINESS WIRE)–After 25 years in prison for a murder he didn’t... Read more.
Global Apheresis Equipment Strategic Market Report 2023: Market to Reach $4.6 Billion by 2030 from $2.5 Billion in 2022 – Rising Incidence of Blood Disorders Fuels Demand – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Apheresis Equipment – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s... Read more.